510(k) K221225
K221225 is an FDA 510(k) premarket notification submitted by Beckman Coulter, Inc. for the device "Access TSH (3rd IS) Assay, DxI 9000 Access Immunoassay Analyzer". The FDA issued a decision of Substantially Equivalent on November 10, 2022. The device falls under product code JLW (Radioimmunoassay, Thyroid-Stimulating Hormone), a Class II device regulated under 21 CFR 862.1690. Beckman Coulter, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 10, 2022
- Date Received
- April 28, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, Thyroid-Stimulating Hormone
- Device Class
- Class II
- Regulation Number
- 862.1690
- Review Panel
- CH
- Submission Type